Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Apollo Hospitals Q4 Results: Net profit rises 36% YoY to ₹529 crore, announces final dividend of ₹10 per share
Apollo Hospitals Enterprise reported strong financial growth for Q4 and FY26, with a 36% YoY increase in net profit to ₹529 crore and an 18% rise in revenue to ₹6,605 crore. EBITDA also grew by 31.5% YoY to ₹1,011 crore.
At 100, the Bajaj Group is writing a new chapter—on healthcare
After 100 years of saying no to diversification, one of India’s fastest-growing wealth engines is finally scratching its ultimate itch. Powered by a ₹5,800-crore dividend chest, the billionaire cousins from the Bajaj Group have said ‘yes’ to one sector: healthcare.
Sohum Asset CIO sees 3-5% more market correction, says buy the dip
Sanjay Parekh, Founder & CIO of Sohum Asset Managers has shifted sharply towards large-cap market leaders, remains cautious on IT, turned positive on Sun Pharma and is selectively betting on renewables through Waaree Energies.
Zydus Lifesciences share price jumps over 6% after Q4 results. Should you buy or sell?
Zydus Lifesciences shares rose over 6% after strong Q4FY26 earnings, reporting a 14.6% increase in net profit to ₹1,592.9 crore. Revenue grew to ₹7,587 crore, driven by the consumer wellness segment. The board approved a ₹1,100 crore share buyback and a Re 1 dividend.
Zydus Lifesciences to pursue acquisitions in specialty, rare diseases
Zydus Lifesciences is set to acquire US firm Assertio Holdings for $166.40 million. This move aims to build a strong specialty oncology business in the US. The company reported robust financial growth for the fourth quarter of 2025-26. Zydus also announced a share buyback and a dividend. Future growth is expected from its specialty portfolio.
Stock Market Highlights: BSE Sensex ends in green after 1,000 point intra-day crash; Nifty50 closes at 23,650 as IT stocks rally comes to rescue - The Times of India
Stock Market Highlights: BSE Sensex ends in green after 1,000 point intra-day crash; Nifty50 closes at 23,650 as IT stocks rally comes to rescueThe Times of IndiaWhy is market falling today? Sensex falls 600 points, Nifty below 23,500; 5 key factors behind bloodbathThe Economic TimesSensex Today Ends Marginally Higher | Nifty Above 23,600 | Gland Pharma Up 15%Equitymaster
Strides Pharma Q4 Results: Operational strength lifts profit despite softer margins
Strides Pharma Science Q4FY26 net profit rose 51 percent to 129.2 crore on 11.2 percent higher revenue, board proposed 5 rupee final dividend, net debt to EBITDA improved to 1.55x
Gland Pharma Declares Rs 20/Share Dividend As Q4 Profit Doubles, Margins Expand; Check Record Date
Gland Pharma Q4
Gland Pharma Q4 profit surges 2x on strong US launches, CDMO growth; declares ₹20 dividend
The board recommended a final dividend of ₹20 per equity share for FY26, subject to shareholder approval. Shares of Gland Pharma Ltd ended at ₹1,861.00, down by ₹34.15, or 1.80%, on the BSE.
Alembic Pharma Q4 profit up 29% as US formulations business grows 11%; declares ₹12 dividend
The company also recommended a dividend of ₹12 per equity share of face value ₹2 each for shareholders. Shares of Alembic Pharmaceuticals Ltd ended at ₹782.10, down by ₹4.35, or 0.55%, on the BSE.
Max Healthcare sets board meeting date to declare Q4 results 2026, final dividend for FY26
Max Healthcare Institute's Board of Directors will meet on May 21, 2026, to review financial results for the quarter and year ended March 31, 2026, and discuss a potential final dividend. The trading window for securities will remain closed until 48 hours after results are declared.
Hester Biosciences Q4 Results: Stock jumps 14% after profit growth, strong operating performance
Hester Biosciences' board has recommended a dividend of ₹11 per equity share for FY26, subject to shareholder approval at the upcoming annual general meeting.